Daniel W. Clarke, Ph.D.: Lawyer with Edwards Wildman Palmer LLP

Daniel W. Clarke, Ph.D.

Boston,  MA  U.S.A.

Peer Rating

Client Rating

Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials

Practice Areas

  • Intellectual Property
  • Patents
  • Licensing
  • Collaborations
  • Joint Ventures & Strategic Alliances
  • Life Sciences
University University of Texas Southwestern Medical Center, Ph.D., Molecular Microbiology; University of Texas, B.A.
Law SchoolSuffolk University Law School, J.D.
AdmittedMassachusetts; U.S. Patent & Trademark Office

Dan is an associate in the Boston office and a member of the Intellectual Property practice group. He focuses his practice on domestic and foreign patent prosecution primarily in the area of biotechnology, including the fields of cellular and molecular biology, oncology, immunology, microbiology, genetic engineering, stem cells, antibody therapeutics, pharmaceuticals, biochemistry, and probiotics.

Dan regularly counsels a broad range of clients, from small biotech start-ups and universities to established pharmaceutical companies.
•Dan prepares and prosecutes U.S. and foreign patent applications with an emphasis in the biological sciences, including drafting applications and responding to Office Actions. Dan's experience also includes drafting patent validity and infringement opinions, freedom-to-operate opinions, and due diligence evaluations of patent portfolios.
•Dan was part of a team that conducted the intellectual property due diligence for the $40 million sale of a crucial client product to a major nutritional company.

Before Edwards Wildman

Prior to joining the firm, Dan was an associate at another international law firm based in Boston, Massachusetts, where he focused on intellectual property matters.

Dan conducted his doctoral research in molecular microbiology. His dissertation focused on characterizing the pathogenic cascade of Acanthamoeba keratitis, a sight-threatening infection of the ocular surface. He was also the recipient of a doctoral training fellowship awarded by UT Southwestern and a grant-in-aid of research from the National Academy of Sciences, awarded by Sigma Xi, the Scientific Research Society.

Dan has authored and presented scientific publications in the fields of immunology, microbiology, parasitology, and ophthalmology.

Besides Edwards Wildman

In his free time, Dan is an avid college sports fan and enjoys cycling, photography, spending time at the gym, and hanging out with family and friends.

Edwards Wildman Client Advisory - U.S. Patent and Trademark Office Issues Guidance in View of Prometheus and Myriad
March 2014 publication
Edwards Wildman Client Advisory: Supreme Court Invalidates Claims to Isolated DNA, but Upholds Patent Eligibility of cDNA in Myriad
June 2013 publication

Edwards Wildman's Daniel Clarke Joins Firm's Intellectual Property Practice, Reports the Boston Media
April 23, 2013


Documents by this lawyer on Martindale.com

Subscribe to this feed

U.S. Patent and Trademark Office Issues Guidance in View of Prometheus and Myriad
Daniel W. Clarke,Peter F. Corless,Christopher R. Cowles,Ralph A. Loren, March 11, 2014
On March 4, 2014, the United States Patent and Trademark Office (USPTO) issued a highly anticipated Guidance for Determining Subject Matter Eligibility of Claims Reciting or Involving Laws of Nature, Natural Phenomena & Natural Products (“Guidance”). The Guidance is promulgated for...
Profile Visibility
#1,970 in weekly profile views out of 19,418 lawyers in Boston, Massachusetts
#133,404 in weekly profile views out of 1,587,858 total lawyers Overall

Office Information

Daniel W. Clarke, Ph.D.

111 Huntington Avenue
BostonMA 02199-7613


Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now